Comments
Loading...

Eli Lilly Analyst Ratings

LLYNYSE
Logo brought to you by Benzinga Data
$818.22
12.991.61%
At close: -
$798.60
-19.62-2.40%
After Hours: 6:49 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$1190.00
Lowest Price Target1
$610.00
Consensus Price Target1
$960.63

Eli Lilly Analyst Ratings and Price Targets | NYSE:LLY | Benzinga

Eli Lilly and Co has a consensus price target of $960.63 based on the ratings of 25 analysts. The high is $1190 issued by Citigroup on January 28, 2025. The low is $610 issued by Daiwa Capital on December 21, 2023. The 3 most-recent analyst ratings were released by Wells Fargo, Truist Securities, and Wells Fargo on March 5, 2025, February 3, 2025, and January 28, 2025, respectively. With an average price target of $1036 between Wells Fargo, Truist Securities, and Wells Fargo, there's an implied 29.73% upside for Eli Lilly and Co from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Dec 24
2
Jan
1
Feb
1
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Wells Fargo
Truist Securities
Citigroup
B of A Securities
Wolfe Research

1calculated from analyst ratings

Analyst Ratings for Eli Lilly

Buy NowGet Alert
03/05/2025Buy Now37.74%Wells Fargo
Mohit Bansal63%
$970 → $1100MaintainsOverweightGet Alert
02/03/2025Buy Now29.98%Truist Securities
Srikripa Devarakonda47%
$1029 → $1038MaintainsBuyGet Alert
01/28/2025Buy Now21.46%Wells Fargo
Mohit Bansal63%
$1000 → $970MaintainsOverweightGet Alert
01/28/2025Buy Now49.01%Citigroup
Peter Verdult22%
$1250 → $1190MaintainsBuyGet Alert
12/10/2024Buy Now24.84%B of A Securities
Tim Anderson54%
→ $997Reinstates → BuyGet Alert
11/15/2024Buy Now25.22%Wolfe Research
Alexandria Hammond51%
→ $1000Initiates → OutperformGet Alert
11/04/2024Buy Now27.1%Deutsche Bank
James Shin42%
$1025 → $1015MaintainsBuyGet Alert
10/31/2024Buy Now22.09%Barclays
Carter Gould58%
$1025 → $975MaintainsOverweightGet Alert
10/31/2024Buy Now37.74%B of A Securities
Geoff Meacham70%
$1150 → $1100MaintainsBuyGet Alert
10/25/2024Buy Now56.52%Citigroup
Peter Verdult22%
$1060 → $1250MaintainsBuyGet Alert
10/17/2024Buy Now37.74%Bernstein → $1100Initiates → OutperformGet Alert
10/10/2024Buy Now29.35%Truist Securities
Srikripa Devarakonda47%
$1000 → $1033MaintainsBuyGet Alert
10/03/2024Buy Now28.35%Deutsche Bank
James Shin42%
$1025 → $1025ReiteratesBuy → BuyGet Alert
09/16/2024Buy Now10.82%Cantor Fitzgerald
Louise Chen57%
$885 → $885ReiteratesOverweight → OverweightGet Alert
09/13/2024Buy Now37.74%JP Morgan
Chris Schott56%
$1050 → $1100MaintainsOverweightGet Alert
09/13/2024Buy Now32.73%Citigroup
Peter Verdult22%
→ $1060ReinstatesBuy → BuyGet Alert
09/09/2024Buy Now10.82%Cantor Fitzgerald
Louise Chen57%
$885 → $885ReiteratesOverweight → OverweightGet Alert
08/27/2024Buy Now38.49%Morgan Stanley
Terence Flynn59%
$1106 → $1106ReiteratesOverweight → OverweightGet Alert
08/19/2024Buy Now10.82%Cantor Fitzgerald
Louise Chen57%
$885 → $885ReiteratesOverweight → OverweightGet Alert
08/16/2024Buy Now28.98%Guggenheim
Seamus Fernandez58%
$884 → $1030MaintainsBuyGet Alert
08/14/2024Buy Now31.48%Berenberg
Kerry Holford56%
$1000 → $1050MaintainsBuyGet Alert
08/12/2024Buy Now28.35%Deutsche Bank
James Shin42%
$725 → $1025UpgradeHold → BuyGet Alert
08/09/2024Buy Now25.22%Wells Fargo
Mohit Bansal63%
$875 → $1000MaintainsOverweightGet Alert
08/09/2024Buy Now37.87%BMO Capital
Evan Seigerman65%
$1001 → $1101MaintainsOutperformGet Alert
08/09/2024Buy Now40.87%B of A Securities
Geoff Meacham70%
$1000 → $1125MaintainsBuyGet Alert
08/05/2024Buy Now10.69%Guggenheim
Seamus Fernandez58%
$855 → $884MaintainsBuyGet Alert
08/05/2024Buy Now10.82%Cantor Fitzgerald
Louise Chen57%
$885 → $885ReiteratesOverweight → OverweightGet Alert
07/24/2024Buy Now10.82%Cantor Fitzgerald
Louise Chen57%
$885 → $885ReiteratesOverweight → OverweightGet Alert
07/15/2024Buy Now10.82%Cantor Fitzgerald
Louise Chen57%
$885 → $885ReiteratesOverweight → OverweightGet Alert
07/11/2024Buy Now25.22%Berenberg
Kerry Holford56%
$850 → $1000MaintainsBuyGet Alert
07/11/2024Buy Now25.22%JP Morgan
Chris Schott56%
$900 → $1000MaintainsOverweightGet Alert
07/10/2024Buy Now28.35%Barclays
Carter Gould58%
$913 → $1025MaintainsOverweightGet Alert
07/05/2024Buy Now28.1%Morgan Stanley
Terence Flynn59%
$1023 → $1023MaintainsOverweightGet Alert
07/03/2024Buy Now25.34%BMO Capital
Evan Seigerman65%
$1001 → $1001MaintainsOutperformGet Alert
07/01/2024Buy Now10.82%Cantor Fitzgerald
Louise Chen57%
$885 → $885ReiteratesOverweight → OverweightGet Alert
06/26/2024Buy Now10.82%Cantor Fitzgerald
Louise Chen57%
$885 → $885ReiteratesOverweight → OverweightGet Alert
06/25/2024Buy Now10.82%Cantor Fitzgerald
Louise Chen57%
$885 → $885ReiteratesOverweight → OverweightGet Alert
06/25/2024Buy Now25.22%Truist Securities
Srikripa Devarakonda47%
$892 → $1000ReiteratesBuy → BuyGet Alert
06/24/2024Buy Now27.1%Jefferies
Akash Tewari45%
$994 → $1015MaintainsBuyGet Alert
06/24/2024Buy Now25.22%B of A Securities
Geoff Meacham70%
$1000 → $1000MaintainsBuyGet Alert
06/24/2024Buy Now10.82%Cantor Fitzgerald
Louise Chen57%
$885 → $885ReiteratesOverweight → OverweightGet Alert
06/20/2024Buy Now10.82%Cantor Fitzgerald
Louise Chen57%
$885 → $885ReiteratesOverweight → OverweightGet Alert
06/17/2024Buy Now10.82%Cantor Fitzgerald
Louise Chen57%
$885 → $885ReiteratesOverweight → OverweightGet Alert
06/12/2024Buy Now10.82%Cantor Fitzgerald
Louise Chen57%
$885 → $885ReiteratesOverweight → OverweightGet Alert
06/11/2024Buy Now10.82%Cantor Fitzgerald
Louise Chen57%
$885 → $885ReiteratesOverweight → OverweightGet Alert
06/07/2024Buy Now19.83%Jefferies
Akash Tewari45%
$925 → $957MaintainsBuyGet Alert
05/14/2024Buy Now5.18%Argus Research
David Toung73%
$770 → $840MaintainsBuyGet Alert
05/01/2024Buy Now25.34%BMO Capital
Evan Seigerman65%
$900 → $1001MaintainsOutperformGet Alert
05/01/2024Buy Now12.7%JP Morgan
Chris Schott56%
$850 → $900MaintainsOverweightGet Alert
05/01/2024Buy Now10.82%Cantor Fitzgerald
Louise Chen57%
$815 → $885MaintainsOverweightGet Alert
05/01/2024Buy Now11.7%Truist Securities
Srikripa Devarakonda47%
$850 → $892MaintainsBuyGet Alert
04/30/2024Buy Now10.82%Cantor Fitzgerald
Louise Chen57%
$815 → $885ReiteratesOverweight → OverweightGet Alert
04/18/2024Buy Now2.05%Cantor Fitzgerald
Louise Chen57%
$815 → $815ReiteratesOverweight → OverweightGet Alert
04/15/2024Buy Now2.05%Cantor Fitzgerald
Louise Chen57%
$815 → $815ReiteratesOverweight → OverweightGet Alert
04/11/2024Buy Now-9.47%Goldman Sachs
Chris Shibutani56%
$650 → $723MaintainsNeutralGet Alert
04/05/2024Buy Now2.05%Cantor Fitzgerald
Louise Chen57%
$815 → $815ReiteratesOverweight → OverweightGet Alert
04/03/2024Buy NowErste Group
Hans Engel62%
UpgradeHold → BuyGet Alert
04/02/2024Buy Now12.07%Citigroup
Andrew Baum72%
$675 → $895MaintainsBuyGet Alert
04/01/2024Buy Now2.05%Cantor Fitzgerald
Louise Chen57%
$815 → $815ReiteratesOverweight → OverweightGet Alert
03/22/2024Buy Now6.44%Truist Securities
Robyn Karnauskas56%
→ $850ReiteratesBuy → BuyGet Alert
03/15/2024Buy Now6.44%JP Morgan
Chris Schott56%
$775 → $850MaintainsOverweightGet Alert
03/01/2024Buy Now25.22%B of A Securities
Geoff Meacham70%
$800 → $1000MaintainsBuyGet Alert
02/21/2024Buy Now2.68%DZ Bank
Elmar Kraus68%
→ $820DowngradeBuy → HoldGet Alert
02/20/2024Buy Now2.05%Cantor Fitzgerald
Louise Chen57%
$815 → $815ReiteratesOverweight → OverweightGet Alert
02/16/2024Buy Now18.96%Morgan Stanley
Terence Flynn59%
$805 → $950MaintainsOverweightGet Alert
02/14/2024Buy Now2.05%Cantor Fitzgerald
Louise Chen57%
$815 → $815ReiteratesOverweight → OverweightGet Alert
02/07/2024Buy Now1.43%Barclays
Carter Gould58%
$680 → $810MaintainsOverweightGet Alert
02/07/2024Buy Now6.44%Truist Securities
Robyn Karnauskas56%
$650 → $850MaintainsBuyGet Alert
02/07/2024Buy Now0.8%Morgan Stanley
David Phung12%
$763 → $805MaintainsOverweightGet Alert
02/07/2024Buy Now3.31%Wells Fargo
Mohit Bansal63%
$700 → $825MaintainsOverweightGet Alert
02/07/2024Buy Now8.31%BMO Capital
Evan Seigerman65%
$710 → $865MaintainsOutperformGet Alert
02/06/2024Buy Now3.31%Wells Fargo
Mohit Bansal63%
$700 → $825MaintainsOverweightGet Alert
02/06/2024Buy Now2.05%Cantor Fitzgerald
Louise Chen57%
$630 → $815MaintainsOverweightGet Alert
02/05/2024Buy Now-21.11%Cantor Fitzgerald
Louise Chen57%
→ $630ReiteratesOverweight → OverweightGet Alert
02/01/2024Buy Now-21.11%Cantor Fitzgerald
Louise Chen57%
$630 → $630ReiteratesOverweight → OverweightGet Alert
01/24/2024Buy Now-12.35%Wells Fargo
Mohit Bansal63%
$650 → $700MaintainsOverweightGet Alert
01/23/2024Buy Now-21.11%Cantor Fitzgerald
Louise Chen57%
$630 → $630ReiteratesOverweight → OverweightGet Alert
01/23/2024Buy Now-14.85%Barclays
Carter Gould58%
$630 → $680MaintainsOverweightGet Alert
12/21/2023Buy Now-23.62%Daiwa Capital
Eli Lilly69%
→ $610DowngradeBuy → OutperformGet Alert
11/29/2023Buy Now-18.61%Truist Securities
Robyn Karnauskas56%
→ $650ReiteratesBuy → BuyGet Alert
11/20/2023Buy Now-21.11%Cantor Fitzgerald
Louise Chen57%
→ $630ReiteratesOverweight → OverweightGet Alert
11/17/2023Buy Now-21.11%Cantor Fitzgerald
Louise Chen57%
→ $630ReiteratesOverweight → OverweightGet Alert
11/15/2023Buy Now-21.11%Cantor Fitzgerald
Louise Chen57%
→ $630ReiteratesOverweight → OverweightGet Alert
11/09/2023Buy Now-33.01%Deutsche Bank
James Shin42%
→ $535Initiates → HoldGet Alert
11/08/2023Buy NowJP Morgan
Chris Schott56%
Reiterates → OverweightGet Alert
11/03/2023Buy Now-9.59%Morgan Stanley
David Phung12%
$673 → $722MaintainsOverweightGet Alert
10/23/2023Buy Now-15.48%Citigroup
Andrew Baum72%
$525 → $675MaintainsBuyGet Alert
10/23/2023Buy Now-21.11%Cantor Fitzgerald
Louise Chen57%
→ $630ReiteratesOverweight → OverweightGet Alert
10/20/2023Buy Now-11.09%UBS
Trung Huynh53%
$612 → $710AssumesBuy → BuyGet Alert
10/11/2023Buy Now-15.73%Morgan Stanley
David Phung12%
$640 → $673MaintainsOverweightGet Alert
10/09/2023Buy Now-21.11%Cantor Fitzgerald
Louise Chen57%
→ $630ReiteratesOverweight → OverweightGet Alert
10/09/2023Buy Now-18.61%Wells Fargo
Mohit Bansal63%
$615 → $650MaintainsOverweightGet Alert
10/02/2023Buy Now-21.11%Cantor Fitzgerald
Louise Chen57%
→ $630ReiteratesOverweight → OverweightGet Alert
09/05/2023Buy Now-22.36%Argus Research
David Toung73%
$470 → $620MaintainsBuyGet Alert
09/05/2023Buy Now-19.86%Morgan Stanley
David Phung12%
$617 → $640MaintainsOverweightGet Alert
09/05/2023Buy Now-21.11%Cantor Fitzgerald
Louise Chen57%
→ $630ReiteratesOverweight → OverweightGet Alert
08/22/2023Buy Now-21.11%Cantor Fitzgerald
Louise Chen57%
→ $630ReiteratesOverweight → OverweightGet Alert
08/10/2023Buy Now-41.15%Goldman Sachs
Chris Shibutani56%
$385 → $470MaintainsNeutralGet Alert
08/09/2023Buy Now-31.13%Cantor Fitzgerald
Louise Chen57%
→ $550ReiteratesOverweight → OverweightGet Alert
08/09/2023Buy Now-24.87%JP Morgan
Chris Schott56%
$510 → $600MaintainsOverweightGet Alert

FAQ

Q

What is the target price for Eli Lilly (LLY) stock?

A

The latest price target for Eli Lilly (NYSE:LLY) was reported by Wells Fargo on March 5, 2025. The analyst firm set a price target for $1100.00 expecting LLY to rise to within 12 months (a possible 37.74% upside). 57 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Eli Lilly (LLY)?

A

The latest analyst rating for Eli Lilly (NYSE:LLY) was provided by Wells Fargo, and Eli Lilly maintained their overweight rating.

Q

When was the last upgrade for Eli Lilly (LLY)?

A

The last upgrade for Eli Lilly and Co happened on August 12, 2024 when Deutsche Bank raised their price target to $1025. Deutsche Bank previously had a hold for Eli Lilly and Co.

Q

When was the last downgrade for Eli Lilly (LLY)?

A

The last downgrade for Eli Lilly and Co happened on February 21, 2024 when DZ Bank changed their price target from N/A to $820 for Eli Lilly and Co.

Q

When is the next analyst rating going to be posted or updated for Eli Lilly (LLY)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Eli Lilly, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Eli Lilly was filed on March 5, 2025 so you should expect the next rating to be made available sometime around March 5, 2026.

Q

Is the Analyst Rating Eli Lilly (LLY) correct?

A

While ratings are subjective and will change, the latest Eli Lilly (LLY) rating was a maintained with a price target of $970.00 to $1100.00. The current price Eli Lilly (LLY) is trading at is $798.60, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch